跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,592 条关于
“Cholangiocarcinoma Foundation”
全部
5,592
临床试验
960
药物
58
机构
474
资讯
4,100
去年
FDA Approves Zanidatamab (Ziihera) for HER2-Positive Biliary Tract Cancer
去年
Tibsovo Listed on Australian PBS, Offering First Targeted Therapy for Rare Bile Duct Cancer
上个月
Sydney Towle, Content Creator Who Documented Cholangiocarcinoma Journey, Dies at 26
去年
FDA Approves Ziihera (zanidatamab-hrii) for HER2-Positive Biliary Tract Cancer
去年
FDA Grants Accelerated Approval to Zanidatamab for HER2+ Biliary Tract Cancer
去年
FDA Approves Ziihera (zanidatamab-hrii) for HER2-Positive Biliary Tract Cancer
11个月前
Zenocutuzumab Shows 37% Response Rate in Rare NRG1-Positive Cholangiocarcinoma
2年前
FDA Grants Orphan Drug Designation to Certepetide for Cholangiocarcinoma
去年
Real-World Data Confirm Ivosidenib Efficacy in IDH1-Mutated Cholangiocarcinoma
2年前
FDA Grants Orphan Drug Designation to CF33-hNIS for Cholangiocarcinoma
第 1 页，共 410 页
上一页
下一页
